These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21074286)

  • 1. Use of the UKPDS Outcomes Model to predict all-cause mortality in U.S. adults with type 2 diabetes mellitus: comparison of predicted versus observed mortality.
    Song M; Alexander CM; Mavros P; Lopez VA; Malik S; Phatak HM; Wong ND
    Diabetes Res Clin Pract; 2011 Jan; 91(1):121-6. PubMed ID: 21074286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.
    Laxy M; Schöning VM; Kurz C; Holle R; Peters A; Meisinger C; Rathmann W; Mühlenbruch K; Kähm K
    Pharmacoeconomics; 2019 Dec; 37(12):1485-1494. PubMed ID: 31350720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato Survey, Italy.
    Pagano E; Gray A; Rosato R; Gruden G; Perin PC; Merletti F; Bruno G
    Diabetologia; 2013 Aug; 56(8):1726-34. PubMed ID: 23680916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey.
    Reynoso-Noverón N; Mehta R; Almeda-Valdes P; Rojas-Martinez R; Villalpando S; Hernández-Ávila M; Aguilar-Salinas CA
    Cardiovasc Diabetol; 2011 Jan; 10():1. PubMed ID: 21214916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the IMS CORE Diabetes Model.
    McEwan P; Foos V; Palmer JL; Lamotte M; Lloyd A; Grant D
    Value Health; 2014 Sep; 17(6):714-24. PubMed ID: 25236995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
    Yew SQ; Chia YC; Theodorakis M
    Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort.
    Keng MJ; Leal J; Mafham M; Bowman L; Armitage J; Mihaylova B
    Value Health; 2022 Mar; 25(3):435-442. PubMed ID: 35227456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
    Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
    Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
    Clarke PM; Gray AM; Briggs A; Farmer AJ; Fenn P; Stevens RJ; Matthews DR; Stratton IM; Holman RR;
    Diabetologia; 2004 Oct; 47(10):1747-59. PubMed ID: 15517152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
    Hayes AJ; Leal J; Gray AM; Holman RR; Clarke PM
    Diabetologia; 2013 Sep; 56(9):1925-33. PubMed ID: 23793713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
    Davis TM; Coleman RL; Holman RR;
    Circulation; 2013 Mar; 127(9):980-7. PubMed ID: 23362315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine.
    Herath HM; Weerarathna TP; Umesha D
    Vasc Health Risk Manag; 2015; 11():583-9. PubMed ID: 26622181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes.
    Hermans MP; Ahn SA; Rousseau MF
    Diabetes Metab; 2009 Dec; 35(6):484-9. PubMed ID: 19897395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM).
    Willis M; Asseburg C; He J
    J Med Econ; 2013 Aug; 16(8):1007-21. PubMed ID: 23718682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves.
    Pandya A; Sy S; Cho S; Alam S; Weinstein MC; Gaziano TA
    Med Decis Making; 2017 Oct; 37(7):802-814. PubMed ID: 28490271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up.
    Svendstrup M; Christiansen MS; Magid E; Hommel E; Feldt-Rasmussen B
    J Diabetes Complications; 2013; 27(6):570-5. PubMed ID: 23932410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrovascular Risk Equations Based on the CANVAS Program.
    Willis M; Asseburg C; Slee A; Nilsson A; Neslusan C
    Pharmacoeconomics; 2021 Apr; 39(4):447-461. PubMed ID: 33580867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cardiovascular risk in adults with type 2 diabetes and metabolic syndrome: Framingham versus UKPDS equations.
    Kim CJ; Kang HS; Schlenk EA; Chae SM
    Diabetes Educ; 2015 Apr; 41(2):203-13. PubMed ID: 25699567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.